ACAN Fundamental Analysis - ACANTHE DEVELOPPEMENT SA

Fundamental Rating

ACAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Diversified REITs industry. No worries on liquidiy or solvency for ACAN as it has an excellent financial health rating, but there are worries on the profitability. ACAN is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ACAN had negative earnings in the past year.

ACAN had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: ACAN reported negative net income in multiple years.

ACAN had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.99%, ACAN is doing worse than 87.50% of the companies in the same industry.

ACAN's Return On Equity of -3.54% is on the low side compared to the rest of the industry. ACAN is outperformed by 82.50% of its industry peers.

The Return On Invested Capital of ACAN (0.54%) is worse than 90.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.99%
ROE	-3.54%
ROIC	0.54%

ROA(3y)-2.84%

ROA(5y)-1.12%

ROE(3y)-3.39%

ROE(5y)-1.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of ACAN (23.36%) is worse than 80.00% of its industry peers.

ACAN's Operating Margin has improved in the last couple of years.

ACAN has a Gross Margin (73.83%) which is in line with its industry peers.

In the last couple of years the Gross Margin of ACAN has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	23.36%
PM (TTM)	N/A
GM	73.83%

OM growth 3YN/A

OM growth 5Y106.65%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-1.25%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACAN is destroying value.

Compared to 1 year ago, ACAN has more shares outstanding

ACAN has more shares outstanding than it did 5 years ago.

The debt/assets ratio for ACAN is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.75 indicates that ACAN is not a great score, but indicates only limited risk for bankruptcy at the moment.

With an excellent Altman-Z score value of 2.75, ACAN belongs to the best of the industry, outperforming 97.50% of the companies in the same industry.

The Debt to FCF ratio of ACAN is 0.87, which is an excellent value as it means it would take ACAN, only 0.87 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 0.87, ACAN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

A Debt/Equity ratio of 0.01 indicates that ACAN is not too dependend on debt financing.

ACAN has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. ACAN outperforms 100.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	0.87
Altman-Z	2.75

ROIC/WACC0.07

WACC7.81%

2.3 Liquidity

A Current Ratio of 2.11 indicates that ACAN has no problem at all paying its short term obligations.

ACAN has a Current ratio of 2.11. This is amongst the best in the industry. ACAN outperforms 92.50% of its industry peers.

A Quick Ratio of 2.11 indicates that ACAN has no problem at all paying its short term obligations.

ACAN has a Quick ratio of 2.11. This is amongst the best in the industry. ACAN outperforms 92.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.11
Quick Ratio	2.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ACAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.08%, which is quite impressive.

The Revenue has decreased by -1.16% in the past year.

ACAN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.49% yearly.

EPS 1Y (TTM)66.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.35%

Revenue 1Y (TTM)-1.16%

Revenue growth 3Y0.44%

Revenue growth 5Y-6.49%

Sales Q2Q%-1.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACAN. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

77.50% of the companies in the same industry are cheaper than ACAN, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	39.45
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ACAN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (7/11/2025, 7:00:00 PM)

0.345

+0.01 (+4.23%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)04-23 2025-04-23

Earnings (Next)09-22 2025-09-22

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners49.25%

Ins Owner ChangeN/A

Market Cap57.05M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.02

Dividend Growth(5Y)-46.74%

DP-70.88%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	14.55
P/FCF	39.45
P/OCF	37.68
P/B	0.51
P/tB	0.51
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.01

FCFY2.53%

OCF(TTM)0.01

OCFY2.65%

SpS0.02

BVpS0.68

TBVpS0.68

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.99%
ROE	-3.54%
ROCE	0.74%
ROIC	0.54%
ROICexc	0.57%
ROICexgc	0.57%
OM	23.36%
PM (TTM)	N/A
GM	73.83%
FCFM	36.88%

ROA(3y)-2.84%

ROA(5y)-1.12%

ROE(3y)-3.39%

ROE(5y)-1.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y110.88%

ROICexc growth 3YN/A

ROICexc growth 5Y110.88%

OM growth 3YN/A

OM growth 5Y106.65%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-1.25%

F-Score5

Asset Turnover0.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	0.87
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	1.73%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.11
Quick Ratio	2.11
Altman-Z	2.75

F-Score5

WACC7.81%

ROIC/WACC0.07

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)3.26%

Cap/Sales(5y)6.74%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)66.08%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.35%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-1.16%

Revenue growth 3Y0.44%

Revenue growth 5Y-6.49%

Sales Q2Q%-1.42%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y110.94%

EBIT growth 3YN/A

EBIT growth 5Y93.23%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-65.58%

FCF growth 3YN/A

FCF growth 5Y20.72%

OCF growth 1Y-65.3%

OCF growth 3YN/A

OCF growth 5Y-16.48%

ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens